Guardian Bio
PrivateLast Round
Seed Round
Mar 3, 2026
Total Funding Raised
$500,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Guardian Bio is a biotechnology company developing a dendritic cell-based platform for cancer therapy to drive anti-tumor activity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guardian Bio Comparables
Compare Guardian Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diakonos Oncology | 84% | |
| CellxLife | 81% | |
| Corner Therapeutics | 78% | |
Guardian Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 3, 2026 | ||||
| Series A | Aug 12, 2024 | ||||
| Seed | Jan 9, 2023 | ||||
| Accelerator | Aug 1, 2022 |
Guardian Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
| Y Combinator | Accelerator |
| Fundament | Accelerator |
| Brazen Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 455% MoM.
- May 20, 2026
Monthly visitors increased 207% MoM, reaching 709.
Guardian Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Guardian Bio's valuation, stock price, and market status.